首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Effect of the drug combination of magnesium sulfate and phentolamine on homocysteine and C-reactive protein in the serum of patients with pregnancy-induced hypertension syndrome
【2h】

Effect of the drug combination of magnesium sulfate and phentolamine on homocysteine and C-reactive protein in the serum of patients with pregnancy-induced hypertension syndrome

机译:硫酸镁和酚妥拉明联合用药对妊娠高血压综合征患者血清同型半胱氨酸和C反应蛋白的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Effect and clinical efficacy of magnesium sulfate combined with phentolamine on homocysteine and C-reactive protein in the serum of patients with pregnancy-induced hypertension syndrome were investigated. A total of 96 patients with pregnancy-induced hypertension syndrome who were diagnosed and treated in Jining No. 1 People's Hospital from February 2016 to January 2018 were retrospectively analyzed. The patients were grouped according to the dosage regimen. The patients who received the combination treatment of magnesium sulfate and phentolamine on the basis of magnesium sulfate were included in the observation group, and the patients who were treated with the intravenous infusion of magnesium sulfate alone were included in the control group. Mean arterial pressure (MAP), the content of 24 h urine protein, systolic blood pressure (SBP), diastolic blood pressure (DBP), Hcy, and CRP of the pregnant women were observed. MAP and the content of 24 h urine protein, SBP and DBP of the patients in the observation group after the treatment were significantly lower than those of the patients in the control group (P<0.001). Hcy and CRP of the patients in the observation group after the treatment were significantly lower than those of the patients in the control group (P<0.001). The total effective rate of the patients in the observation group was significantly higher than that of the patients in the control group (P<0.05). In conclusion, the meliorative effect of magnesium sulphate combined with phentolamine on the level of MAP, the content of 24 h urine protein, SBP, DBP, Hcy and CRP in pregnant woman had a greater impact than that of the single use of the intravenous infusion of magnesium sulfate in the treatment of pregnancy-induced hypertension syndrome, and the clinical efficacy of magnesium sulphate combined with phentolamine was better, thus worthwhile to promote widely in clinic.
机译:研究了硫酸镁联合酚妥拉明对妊娠高血压综合征患者血清同型半胱氨酸和C反应蛋白的影响及其临床疗效。回顾性分析2016年2月至2018年1月在济宁市第一人民医院诊治的96例妊娠高血压综合征患者。根据剂量方案将患者分组。观察组包括以硫酸镁为基础接受硫酸镁和酚妥拉明联合治疗的患者,对照组为仅接受静脉内输注硫酸镁治疗的患者。观察孕妇的平均动脉压(MAP),24 h尿蛋白含量,收缩压(SBP),舒张压(DBP),Hcy和CRP。治疗后观察组患者MAP,24 h尿蛋白,SBP,DBP含量明显低于对照组(P <0.001)。治疗后观察组患者的Hcy和CRP显着低于对照组(P <0.001)。观察组总有效率明显高于对照组(P <0.05)。综上所述,硫酸镁联合酚妥拉明对孕妇MAP水平,24h尿蛋白,SBP,DBP,Hcy和CRP含量的改善作用比单次静脉输注的影响更大。硫酸镁治疗妊娠高血压综合征的疗效较好,硫酸镁联合酚妥拉明的临床疗效较好,值得临床推广。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号